Related Experiment Video
Updated: Oct 24, 2025
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
603
CPT: Pharmacometrics and Systems Pharmacology
1Editor-in-Chief.
CPT: Pharmacometrics & Systems Pharmacology
|July 10, 2013
Summary
CPT: Pharmacometrics and Systems Pharmacology (CPT:PSP) is a new journal. It focuses on quantitative, model-based approaches in pharmacology and disease to advance human therapeutics discovery and development.
Area of Science:
- Pharmacometrics and Systems Pharmacology
- Clinical Pharmacology and Therapeutics
Background:
- CPT:PSP is a new journal from the American Society for Clinical Pharmacology and Therapeutics.
- It is a cross-disciplinary journal.
- The journal focuses on quantitative, model-based approaches.
Purpose of the Study:
- To publish advances in quantitative, model-based approaches in pharmacology, (patho)physiology, and disease.
- To aid the discovery, development, and utilization of human therapeutics.
- To emphasize the application of modeling and simulation and the impact of Pharmacometrics and Systems Pharmacology on innovative therapies.
Main Methods:
- The journal publishes advances in quantitative, model-based approaches.
- It emphasizes the application of modeling and simulation.
- It highlights the impact of Pharmacometrics and Systems Pharmacology.
Main Results:
- The first issue of CPT:PSP has been published.
- The journal aims to advance the discovery and development of innovative therapies.
Conclusions:
- CPT:PSP is a valuable resource for researchers and clinicians in the field.
- The journal will contribute to the advancement of human therapeutics.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
35
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
35
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
275
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
275
01:26Pharmacokinetic Models: Comparison and Selection Criterion
178
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
178
01:12Analysis of Population Pharmacokinetic Data
473
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
473
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
149
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
149
01:20Pharmacokinetic Models: Overview
1.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.4K